Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment.
Bouchet A, Muller B, Olagne J, Barba T, Joly M, Obrecht A, Rabeyrin M, Dijoud F, Picard C, Mezaache S, Sicard A, Koenig A, Parissiadis A, Dubois V, Morelon E, Caillard S, Thaunat O.
Bouchet A, et al. Among authors: picard c.
Nephrol Dial Transplant. 2022 Nov 23;37(12):2555-2568. doi: 10.1093/ndt/gfac192.
Nephrol Dial Transplant. 2022.
PMID: 35675302